Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of a novel antimalarial compound, CHMFL-PI4K-127

April 9, 2020

Enanta Pharmaceuticals identifies compounds for HBV infection

April 9, 2020

MediciNova to initiate clinical trial of ibudilast for COVID-19 ARDS

April 9, 2020

Cardurion Pharmaceuticals presents CAMK2 inhibitors

April 9, 2020

Thomas Jefferson University develops COVID-19 vaccine candidate

April 9, 2020

Clinical trial application for ACN-00177 approved in the U.K.

April 9, 2020

Ariagen patents prodrugs for cancer

April 9, 2020

Program to prevent the severe respiratory effects of COVID-19 using LAMELLASOME technology

April 9, 2020

Active compound of WP-1122 reduces coronavirus replication in vitro

April 9, 2020

Biophytis launches COVA clinical program of Sarconeos in COVID-19

April 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...